Literature DB >> 23774884

Multidrug-resistant pathogens in hospitalised patients coming from the community with pneumonia: a European perspective.

Stefano Aliberti1, Catia Cilloniz, James D Chalmers, Anna Maria Zanaboni, Roberto Cosentini, Paolo Tarsia, Alberto Pesci, Francesco Blasi, Antoni Torres.   

Abstract

BACKGROUND: Probabilistic scores have been recently suggested to identify pneumonia caused by multidrug-resistant (MDR) bacteria. The aim of the study was to validate both Aliberti and Shorr scores in predicting MDR pneumonia, comparing them with healthcare associated pneumonia (HCAP) classification.
METHODS: Two independent European cohorts of consecutive patients hospitalised with pneumonia were prospectively evaluated in Barcelona, Spain (BC) and Edinburgh, UK (EC). Data on admission and during hospitalisation were collected. The predictive value of the three scores was explored for correctly indicating the presence of MDR pneumonia via a receiver-operating characteristic (ROC) curve.
RESULTS: A total of 1591 patients in the BC and 1883 patients in the EC were enrolled. The prevalence of patients with MDR pathogen among those with isolated bacteria was 7.6% in the BC and 3.3% in the EC. The most common MDR pathogen found in both cohorts was MRSA, followed by MDR P aeruginosa. A significantly higher prevalence of MDR bacteria was found among patients in the intensive care unit (ICU). The two probabilistic scores, and particularly the Aliberti one, showed an area under the ROC curve higher than the HCAP classification in predicting MDR pneumonia, especially in the ICU.
CONCLUSIONS: Risk scores able to identify MDR pneumonia could help in developing strategies for antimicrobial stewardship.

Entities:  

Keywords:  Bacterial Infection; Pneumonia; Respiratory Infection

Mesh:

Year:  2013        PMID: 23774884     DOI: 10.1136/thoraxjnl-2013-203384

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  42 in total

1.  What's new in antimicrobial use and resistance in critically ill patients?

Authors:  Matteo Bassetti; David P Nicolau; Thierry Calandra
Journal:  Intensive Care Med       Date:  2013-12-18       Impact factor: 17.440

2.  Healthcare-associated pneumonia: where do we go next?

Authors:  Marcos I Restrepo; Stefano Aliberti
Journal:  Clin Infect Dis       Date:  2013-11-22       Impact factor: 9.079

3.  Healthcare-associated pneumonia: another nail in the coffin?

Authors:  Pieter Depuydt; Christian Brun-Buisson
Journal:  Intensive Care Med       Date:  2014-03-18       Impact factor: 17.440

Review 4.  Carbon nanotubes as anti-bacterial agents.

Authors:  Teodora Mocan; Cristian T Matea; Teodora Pop; Ofelia Mosteanu; Anca Dana Buzoianu; Soimita Suciu; Cosmin Puia; Claudiu Zdrehus; Cornel Iancu; Lucian Mocan
Journal:  Cell Mol Life Sci       Date:  2017-05-23       Impact factor: 9.261

5.  Rapid Detection of Methicillin-Resistant Staphylococcus aureus in BAL: A Pilot Randomized Controlled Trial.

Authors:  Joseph R Paonessa; Raj D Shah; Chiagozie I Pickens; Bryan D Lizza; Helen K Donnelly; Michael Malczynski; Chao Qi; Richard G Wunderink
Journal:  Chest       Date:  2019-02-15       Impact factor: 9.410

6.  Health care-associated pneumonia in the intensive care unit: Guideline-concordant antibiotics and outcomes.

Authors:  Russell T Attridge; Christopher R Frei; Mary Jo V Pugh; Kenneth A Lawson; Laurajo Ryan; Antonio Anzueto; Mark L Metersky; Marcos I Restrepo; Eric M Mortensen
Journal:  J Crit Care       Date:  2016-08-11       Impact factor: 3.425

7.  Derivation and Multicenter Validation of the Drug Resistance in Pneumonia Clinical Prediction Score.

Authors:  Brandon J Webb; Kristin Dascomb; Edward Stenehjem; Holenarasipur R Vikram; Neera Agrwal; Kenneth Sakata; Kathryn Williams; Bruno Bockorny; Kavitha Bagavathy; Shireen Mirza; Mark Metersky; Nathan C Dean
Journal:  Antimicrob Agents Chemother       Date:  2016-04-22       Impact factor: 5.191

Review 8.  Risk Factors for Drug-Resistant Cap in Immunocompetent Patients.

Authors:  Francisco Arancibia; Mauricio Ruiz
Journal:  Curr Infect Dis Rep       Date:  2017-03       Impact factor: 3.725

9.  Empirical Anti-MRSA vs Standard Antibiotic Therapy and Risk of 30-Day Mortality in Patients Hospitalized for Pneumonia.

Authors:  Barbara Ellen Jones; Jian Ying; Vanessa Stevens; Candace Haroldsen; Tao He; McKenna Nevers; Matthew A Christensen; Richard E Nelson; Gregory J Stoddard; Brian C Sauer; Peter M Yarbrough; Makoto M Jones; Matthew Bidwell Goetz; Tom Greene; Matthew H Samore
Journal:  JAMA Intern Med       Date:  2020-04-01       Impact factor: 21.873

10.  Clinical predictors of methicillin-resistant Staphylococcus aureus in nosocomial and healthcare-associated pneumonia: a multicenter, matched case-control study.

Authors:  J Torre-Cisneros; C Natera; F Mesa; M Trikic; J Rodríguez-Baño
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-09-08       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.